Facebook
Twitter
LinkedIn
ForwardPharmacogenomics in Clinical Practice_Enduring
Precision medicine is a growing field in healthcare, and pharmacogenomics (PGx) is the leading use case for this expansion. The role of the pharmacist in PGx is new, and resources are now available to guide decision-making and patient care. Understanding the science behind PGx and practical application of this science to the care of patients is an emerging healthcare approach. This session will overview the science,and provide two clinical settings where PGx programs have been successfully implemented.
The main focus of the session will be to review the science behind PGx, and then share two different examples of pharmacist-driven PGx programs and the role of the pharmacist on the team of specialists.
Target Audience
Nurse
Nurse Practitioner
Pharmacist
Pharmacy Technician
Physician
Physician Assistant
Learning Objectives
Pharmacogenomics (PGx): Science Driving Implementation -- Philip E. Empey, PharmD, PhD
Upon completion of this activity, participants should be able to:
- Describe why PGx is a leading use case for precision medicine and the role of pharmacists.
- Identify pharmacogenomic resources that provide actionable information regarding how genetic variation in a large number of proteins, including drug transporters, drug metabolizing enzymes impacts drug response.
- Discuss the current pharmacogenomic reimbursement landscape.
Clinical Applications of PGx in the Hospital Setting -- James C. Coons, PharmD, FCCP, FACC, BCCP
Upon completion of this activity, participants should be able to:
- Describe an example of clinical PGx implementation program in the acute care setting.
- Explain the role of a pharmacist in a hospital-based PGx implementation program.
- Highlight the impact of an inpatient PGx program on patient outcomes.
Clinical Applications of PGx in Primary Care -- Lucas A. Berenbrok, PharmD, MS, BCACP, TTS
Upon completion of this activity, participants should be able to:
- Describe an example clinical PGx service in primary care.
- Explain the role of pharmacists in outpatient PGx services.
- Highlight how preemptive and reactive PGx testing can impact patient outcomes.
- Philip E. Empey, PharmD, PhD, FCCP - Director, Pharmacogenomics Center of Excellence; Associate Director of Pharmacogenomics, Institute for Precision Medicine; and Associate Professor, School of Pharmacy, University of Pittsburgh
- James C. Coons, PharmD, FCCP, FACC, BCCP - Clinical Pharmacist, Cardiology, UPMC Presbyterian Hospital; PGY2 Cardiology Residency Director; and Professor, School of Pharmacy, University of Pittsburgh
- Lucas A. Berenbrok, PharmD, MS, BCACP - Associate Professor, Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh
Dr. Empey is a consultant for Cipherome, and Pfizer.
Dr. Seybert disclosed she completed 2 advisory meetings with Pfizer.
Dr. Coons disclosed he receives grant/research support from United Therapeutics, and Pfizer-Bristol Myers-Squibb Alliance. In addition, he is a consultant for Pfizer-Bristol Myers-Squibb Alliance.
Course Planners
- Susan Skledar, RPh, MPH, FASHP - Director of Experiential Learning, Professor, Department of Pharmacy & Therapeutics, University of Pittsburgh School of Pharmacy
- Amy Seybert, PharmD - Chair of the Department of Pharmacy and Therapeutics as well as the Pharmacy Residency Administrator at UPMC
Authors disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (ACPE)
This knowledge-based activity provides 2.0 contact hours of continuing pharmacy education credit.
JA4008223-0000-23-055-H04-P.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 2.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 2.00 Attendance